Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot2 - STU 1 ballot International flag

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

Example Composition: M11 IGBJ Protocol Example for EBMonFHIR IG

Page standards status: Informative

Generated Narrative: Composition 256358

version: 61; Last updated: 2025-03-10 10:47:05+0000

Profile: M11Report

Artifact Description:

This is an example of how an M11 Report can be supported in FHIR Profiles. This example may be actively revised in the Vulcan UDP meetings and Connectathons.

url: https://fevir.net/resources/Composition/256358

identifier: FEvIR Object Identifier/https://fevir.net/FOI/256358

status: Final

type: CeSHarP Report

date: 2025-03-10 10:47:05+0000

author: Brian S. Alper

title: M11 IGBJ Protocol Example for EBMonFHIR IG

custodian: Computable Publishing LLC

relatesTo

type: Cite As

target:

M11 IGBJ Protocol Example for EBMonFHIR IG [Database Entry: FHIR Composition Resource]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 256358. Revised 2025-03-07. Available at: https://fevir.net/resources/Composition/256358. Computable resource at: https://fevir.net/FLI/DocumentForComposition256358.

relatesTo

type: Derived From

target: A Study of Nasal Glucagon (LY900018) in Japanese Participants With Diabetes Mellitus - M11 Example